• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: THORATEC SWITZERLAND GMBH CENTRIMAG BLOOD PUMP; PUMP, BLOOD, CARDIOPULMONARY BYPASS, NON-ROLLER TYPE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

THORATEC SWITZERLAND GMBH CENTRIMAG BLOOD PUMP; PUMP, BLOOD, CARDIOPULMONARY BYPASS, NON-ROLLER TYPE Back to Search Results
Model Number 102953
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Hemorrhage/Bleeding (1888); Renal Failure (2041); Cardiogenic Shock (2262); Heart Failure/Congestive Heart Failure (4446)
Event Date 06/16/2021
Event Type  Death  
Manufacturer Narrative
Patient information was not provided.No further information was provided.A supplemental report will be submitted when the manufacturer¿s investigation is completed.
 
Event Description
It was reported that the patient had renal dysfunction.Continuous renal replacement therapy (crrt) was initiated on (b)(6) 2021 (before centrimag implant) and the subject then had no urine output.The patient was reported to have a high volume output from chest tube, the patient was required to go to the operating room for a procedure.Blood products were administered.The patient passed away on (b)(6) 2021 due to multiorgan failure from cardiogenic shock.No additional information was provided.
 
Manufacturer Narrative
No further information was provided.A supplemental report will be submitted when the manufacturer¿s investigation is complete.
 
Event Description
It was reported that the patient was admitted on (b)(6) 2021 due to worsening shortness of breath on even mild exertion and at rest, severe orthopnea, and worsening lower extremity edema.Transthoracic echocardiography (tte) on admission visualized the apical septal ventricular septal defect (vsd).Left ventricular ejection fraction (lvef) was noted to be 40%, and severe tricuspid regurgitation and mild mitral regurgitation were reported.The patient continued to decline and on (b)(6) 2021 the patient underwent a right heart catheter and intra-aortic balloon pump (iabp) placement.The patient was taken to the operating room for urgent ventricular septal defect (vsd) repair and central extracorporeal membrane oxygenation (ecmo) placement.The patient had a bedside chest washout on (b)(6) 2021 with improvement in chest wall bleeding from the sternal fracture.The patient remained critically ill on ecmo and crrt with significant coagulopathy.On (b)(6) 2021 after extensive discussion with the family and poor prognosis, the decision was made to withdraw care.
 
Manufacturer Narrative
Manufacturer's investigation conclusion: a direct correlation between the reported events and the centrimag device could not be conclusively established through this evaluation.Review of the device history record (dhr) for the centrimag blood pump revealed no deviations from manufacturing or quality assurance specifications.The centrimag blood pump instructions for use (ifu) lists bleeding, multiple types of organ failure and dysfunction (hepatic dysfunction, renal dysfunction, respiratory failure, and right heart failure), and death as adverse events that may be associated with the centrimag circulatory support system.This ifu also provides the following warnings and cautions: ifu warning 7: it is intended that systemic anticoagulation be utilized while the device is in use.Anticoagulation levels should be determined by the physician based on risks and benefits to the patient.Ifu warning #10: frequent patient and device monitoring is recommended.Ifu caution #2: this device should only be used by persons thoroughly trained in extracorporeal circulation procedures.Ifu caution #15: always have a backup centrimag pump, console, motor, and accessories available for use.No further information was provided.The manufacturer is closing the file on this event.
 
Manufacturer Narrative
No further information was provided.The manufacturer is closing the file on this event.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
CENTRIMAG BLOOD PUMP
Type of Device
PUMP, BLOOD, CARDIOPULMONARY BYPASS, NON-ROLLER TYPE
Manufacturer (Section D)
THORATEC SWITZERLAND GMBH
technoparkstrasse 1
zurich CH-80 05
SZ  CH-8005
MDR Report Key12120468
MDR Text Key259988654
Report Number3003306248-2021-02988
Device Sequence Number1
Product Code KFM
UDI-Device Identifier07640135140627
UDI-Public07640135140627
Combination Product (y/n)N
PMA/PMN Number
K020271
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type health professional,study
Type of Report Initial,Followup,Followup,Followup
Report Date 09/17/2021
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received07/06/2021
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Lay User/Patient
Device Expiration Date04/30/2022
Device Model Number102953
Device Catalogue Number102953
Device Lot Number70140115
Was Device Available for Evaluation? No
Was the Report Sent to FDA? No
Date Manufacturer Received09/16/2021
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Patient Outcome(s) Death; Life Threatening;
Patient Age63 YR
Patient Weight143
-
-